0.00
—
Close of 30 Oct 2026, in USD
About HLK Biotec Holding Group
Its shares trade under the ticker AMHD. It has been listed since 21 June 2001. In the fiscal year to 31 December 2016, it reported revenue of $8,329 and a net loss of $3,769. At that date it held total assets of $116,707 and shareholders' equity of $51,919.
HLK Biotech Holding Group, Inc. operates as a holding company. The company is headquartered in Norfolk, Virginia. The company went IPO on 2001-06-21. The firm is engaged in the manufacture of renewable fuels. The firm's containerized units produce approximately 2.5 million gallons per year (MGPY) of biodiesel and approximately 250,000 gallons of crude glycerin. The firm's subsidiaries include Amelot Oil Barbados Limited, Amelot Oil, Inc., Amelot Oil Trinidad & Tobago Limited, Amelot Oil Ghana Limited, and Amelot Properties, LLC. Amelot Oil, Inc. was formed in order to focus on the biodiesel production. Amelot Oil Barbados Limited operates a biodiesel plant, which is located in Barbados.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 21 Jun 2001
- Employees
- 6
Leadership
Pay as last reported
- Aziz HirjiChairman of the Board, President, Chief Executive Officer, since 1998
- Peter MaharajVice President of Marketing and President of The Subsidiary, since 1999
- Hank MiddenVice President-Operations, since 1999$90,000
- Anna PetinovaInterim Vice President of Finance and Administration, Secretary, Treasurer, Director, since 1998
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- HLK Biotec Holding Group Inc possesses several strengths that contribute to its success:
- Strong research and development capabilities enable the company to innovate and develop high-quality biotech products.
- Wide range of products offering in the biotech industry, catering to diverse customer needs.
- Established reputation and brand recognition in the market.
Weaknesses
- Despite its strengths, HLK Biotec Holding Group Inc does face certain weaknesses:
- Limited global presence compared to some competitors, which restricts market reach.
- Dependence on a few key suppliers for raw materials, hence vulnerable to supply chain disruptions.
- Relatively high production costs compared to some competitors.
Opportunities
- HLK Biotec Holding Group Inc has several opportunities for growth:
- Rising demand for biotech products globally, driven by increasing healthcare awareness and research investments.
- Expansion into emerging markets with large populations and growing healthcare sectors.
- Collaboration with academic institutions and research centers to enhance innovation and product development.
Threats
- HLK Biotec Holding Group Inc faces certain threats that could impact its performance:
- Intense competition from both established biotech companies and new market entrants.
- Regulatory changes and compliance requirements, which could increase costs and affect product development.
- Economic downturns or recessions that may lead to lower consumer spending on biotech products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.